» Articles » PMID: 32947487

Evaluation of Plasma Biomarker Utility for the Gastrointestinal Acute Radiation Syndrome in Non-human Primates After Partial Body Irradiation with Minimal Bone Marrow Sparing Through Correlation with Tissue and Histological Analyses

Overview
Journal Health Phys
Date 2020 Sep 18
PMID 32947487
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Exposure to total- and partial-body irradiation following a nuclear or radiological incident result in the potentially lethal acute radiation syndromes of the gastrointestinal and hematopoietic systems in a dose- and time-dependent manner. Radiation-induced damage to the gastrointestinal tract is observed within days to weeks post-irradiation. Our objective in this study was to evaluate plasma biomarker utility for the gastrointestinal acute radiation syndrome in non-human primates after partial body irradiation with minimal bone marrow sparing through correlation with tissue and histological analyses. Plasma and jejunum samples from non-human primates exposed to partial body irradiation of 12 Gy with bone marrow sparing of 2.5% were evaluated at various time points from day 0 to day 21 as part of a natural history study. Additionally, longitudinal plasma samples from non-human primates exposed to 10 Gy partial body irradiation with 2.5% bone marrow sparing were evaluated at timepoints out to 180 d post-irradiation. Plasma and jejunum metabolites were quantified via liquid chromatography-tandem mass spectrometry and histological analysis consisted of corrected crypt number, an established metric to assess radiation-induced gastrointestinal damage. A positive correlation of metabolite levels in jejunum and plasma was observed for citrulline, serotonin, acylcarnitine, and multiple species of phosphatidylcholines. Citrulline levels also correlated with injury and regeneration of crypts in the small intestine. These results expand the characterization of the natural history of gastrointestinal acute radiation syndrome in non-human primates exposed to partial body irradiation with minimal bone marrow sparing and also provide additional data toward the correlation of citrulline with histological endpoints.

Citing Articles

Metabolomics identifies plasma biomarkers of localized radiation injury.

Ancel L, Grison S, Gabillot O, Gueguen J, Svilar L, Guen B Sci Rep. 2025; 15(1):2166.

PMID: 39819895 PMC: 11739571. DOI: 10.1038/s41598-025-85717-5.


Gastrointestinal Acute Radiation Syndrome: Mechanisms, Models, Markers, and Medical Countermeasures.

Winters T, Marzella L, Molinar-Inglis O, Price P, Han N, Cohen J Radiat Res. 2024; 201(6):628-646.

PMID: 38616048 PMC: 11658916. DOI: 10.1667/RADE-23-00196.1.


Radiation-induced multi-organ injury.

Molinar-Inglis O, DiCarlo A, Lapinskas P, Rios C, Satyamitra M, Silverman T Int J Radiat Biol. 2024; 100(3):486-504.

PMID: 38166195 PMC: 11874064. DOI: 10.1080/09553002.2023.2295298.


Effects of Gamma-Tocotrienol on Partial-Body Irradiation-Induced Intestinal Injury in a Nonhuman Primate Model.

Garg S, Garg T, Miousse I, Wise S, Fatanmi O, Savenka A Antioxidants (Basel). 2022; 11(10).

PMID: 36290618 PMC: 9598988. DOI: 10.3390/antiox11101895.


Development of Biomarkers for Radiation Biodosimetry and Medical Countermeasures Research: Current Status, Utility, and Regulatory Pathways.

Satyamitra M, DiCarlo A, Hollingsworth B, Winters T, Taliaferro L Radiat Res. 2021; 197(5):514-532.

PMID: 34879151 PMC: 9119904. DOI: 10.1667/RADE-21-00157.1.


References
1.
MacVittie T, Bennett A, Farese A, Taylor-Howell C, Smith C, Gibbs A . The Effect of Radiation Dose and Variation in Neupogen® Initiation Schedule on the Mitigation of Myelosuppression during the Concomitant GI-ARS and H-ARS in a Nonhuman Primate Model of High-dose Exposure with Marrow Sparing. Health Phys. 2015; 109(5):427-39. PMC: 9442798. DOI: 10.1097/HP.0000000000000350. View

2.
Parker G, Cohen E, Li N, Takayama K, Farese A, MacVittie T . Radiation Nephropathy in a Nonhuman Primate Model of Partial-Body Irradiation With Minimal Bone Marrow Sparing-Part 2: Histopathology, Mediators, and Mechanisms. Health Phys. 2019; 116(3):409-425. PMC: 6349488. DOI: 10.1097/HP.0000000000000935. View

3.
Jones J, Scott A, Tudor G, Xu P, Jackson I, Vujaskovic Z . Identification and quantitation of biomarkers for radiation-induced injury via mass spectrometry. Health Phys. 2013; 106(1):106-19. PMC: 3843144. DOI: 10.1097/HP.0b013e3182a4ed3b. View

4.
Potten C . A comprehensive study of the radiobiological response of the murine (BDF1) small intestine. Int J Radiat Biol. 1990; 58(6):925-73. DOI: 10.1080/09553009014552281. View

5.
Prado C, MacVittie T, Bennett A, Kazi A, Farese A, Prado K . Organ Doses Associated with Partial-Body Irradiation with 2.5% Bone Marrow Sparing of the Non-Human Primate: A Retrospective Study. Radiat Res. 2017; 188(6):615-625. DOI: 10.1667/RR14804.1. View